comparemela.com

Latest Breaking News On - Manuel esteban shutterstock - Page 5 : comparemela.com

Covid-19 Vaccine Roundup: 5 Pharma Stocks Making the Biggest Headlines Today

Covid-19 Vaccine Roundup: 5 Pharma Stocks Making the Biggest Headlines Today InvestorPlace 1/20/2021 Sarah Smith © Source: Shutterstock A needle rests on a reflective table next two clear glass vials of a clear liquid. As President-elect Joe Biden takes office, one of the key issues at hand is the national Covid-19 response. Who receives vaccines, and when? And how can the United States speed up the vaccination process? Pharma stocks are in the crosshairs as Biden retires Operation Warp Speed and implements his own plan. Dive in with InvestorPlace below for our Covid-19 vaccine roundup. © Provided by InvestorPlace A needle rests on a reflective table next two clear glass vials of a clear liquid.

Pfizer s All-in Costs Show Vaccine Probably Won t Move the Needle Much

Pfizer’s All-in Costs Show Vaccine Probably Won’t Move the Needle Much InvestorPlace 12/29/2020 Larry Ramer © Source: Manuel Esteban / Shutterstock.com Here s How Pfizer Stock (and Pharma) Stand to Benefit From Mylan Deal Due to a combination of several factors, Pfizer’s (NYSE: PFE) vaccine for the novel coronavirus, by itself, may not ever move the needle a great deal for PFE stock. © Provided by InvestorPlace Here s How Pfizer Stock (and Pharma) Stand to Benefit From Mylan Deal On the other hand, over the long-term, Pfizer’s collaboration with German vaccine developer BioNTech (NASDAQ: BNTX), which developed the mRNA-based coronavirus vaccine with Pfizer, could prove to be meaningfully beneficial for the owners of Pfizer’s shares.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.